2.68
전일 마감가:
$2.79
열려 있는:
$2.73
하루 거래량:
85,743
Relative Volume:
0.04
시가총액:
$8.64M
수익:
$12.99M
순이익/손실:
$-23.72M
주가수익비율:
-0.0276
EPS:
-97.2514
순현금흐름:
$-23.28M
1주 성능:
-12.42%
1개월 성능:
-9.15%
6개월 성능:
-96.94%
1년 성능:
-99.10%
Aptevo Therapeutics Inc Stock (APVO) Company Profile
명칭
Aptevo Therapeutics Inc
전화
206-838-0500
주소
2401 4TH AVE., SEATTLE, WA
APVO을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
APVO
Aptevo Therapeutics Inc
|
2.68 | 9.00M | 12.99M | -23.72M | -23.28M | -97.25 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2018-11-05 | 개시 | Ladenburg Thalmann | Buy |
2017-10-05 | 재개 | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc 주식(APVO)의 최신 뉴스
Is Aptevo Therapeutics Inc. a good long term investmentMaximize portfolio growth with expert advice - jammulinksnews.com
Why is Aptevo Therapeutics Inc. stock attracting strong analyst attentionCapitalize on emerging growth stocks - jammulinksnews.com
Does Aptevo Therapeutics Inc. stock perform well during market downturnsTremendous wealth creation - jammulinksnews.com
How does Aptevo Therapeutics Inc. compare to its industry peersDiscover high-impact stocks for your portfolio - jammulinksnews.com
Is it the right time to buy Aptevo Therapeutics Inc. stockHigh-octane financial growth - jammulinksnews.com
When is Aptevo Therapeutics Inc. stock expected to show significant growthInvest smarter with actionable market insights - jammulinksnews.com
What drives Aptevo Therapeutics Inc. stock priceUnlock daily market insights for better trades - jammulinksnews.com
What are the latest earnings results for Aptevo Therapeutics Inc.Build a portfolio for long-term financial success - jammulinksnews.com
Should I hold or sell Aptevo Therapeutics Inc. stock in 2025Unlock your trading potential today - jammulinksnews.com
What institutional investors are buying Aptevo Therapeutics Inc. stockInvest smarter with real-time trading signals - jammulinksnews.com
What are Aptevo Therapeutics Inc. company’s key revenue driversBuild wealth faster with consistent growth stocks - jammulinksnews.com
What are the technical indicators suggesting about Aptevo Therapeutics Inc.Wealth Building Trend Scanner For Smart Trading - jammulinksnews.com
Historical volatility pattern of Aptevo Therapeutics Inc. visualizedCapital Protection Trading Strategies Gain Interest - metal.it
Aptevo Therapeutics Inc. Shows Support at Fibonacci LevelFree Elite Traders Group - beatles.ru
How strong is Aptevo Therapeutics Inc. company’s balance sheetExplosive portfolio gains - jammulinksnews.com
How does Aptevo Therapeutics Inc. generate profit in a changing economyGet alerts on the hottest market movers - jammulinksnews.com
What is Aptevo Therapeutics Inc. company’s growth strategyInvest smarter with advanced market data - jammulinksnews.com
How volatile is Aptevo Therapeutics Inc. stock compared to the marketTrack emerging stocks with high growth potential - jammulinksnews.com
Is Aptevo Therapeutics Inc. a Top Dividend Stock to Watch in 2025Top Gaining Low Risk Assets - metal.it
Is Aptevo Therapeutics Inc. a growth stock or a value stockTransform your portfolio with high-yield stocks - jammulinksnews.com
Aptevo Therapeutics' Equity Offering: Strategic Opportunity or Investor Warning? - AInvest
Aptevo Therapeutics Inc. Stock Analysis and ForecastMarket-crushing profits - PrintWeekIndia
Aptevo Therapeutics Files Registration Statement for Share Resale by Stockholder - 富途牛牛
Aptevo Therapeutics' Share Resale and Its Implications for Liquidity and Shareholder Value - AInvest
Aptevo Therapeutics files to sell 8.25M shares of common stock for holders - MSN
Aptevo Therapeutics' $8M Share and Warrant Offering: Balancing Dilution with Strategic Clinical Development - AInvest
Aptevo Therapeutics (APVO) Schedules Offering of 8.25 Million Shares - GuruFocus
What analysts say about Aptevo Therapeutics Inc. stockHigh-profit stock alerts - PrintWeekIndia
Is Aptevo Therapeutics Inc. stock a growth or value playRapid market gains - jammulinksnews.com
Aptevo Therapeutics shareholders approve all proposals at annual meeting By Investing.com - Investing.com Nigeria
Aptevo Therapeutics shareholders approve all proposals at annual meeting - Investing.com
Aptevo Therapeutics Holds Annual Stockholders Meeting - TipRanks
Will Aptevo Therapeutics Inc. stock benefit from AI tech trendsExceptional risk-adjusted gains - jammulinksnews.com
Aptevo Therapeutics Inc (APVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):